In a groundbreaking initiative to treat severe mental health conditions, a new research group in Cambridgeshire is conducting clinical trials to investigate the potential benefits of empathogens and psychedelics.
COVID-19 activates the same inflammatory response in the brain as Parkinson’s disease – increasing the risk of future potential neurodegenerative conditions.
Sabine Hölter, Coordinator of the European Brain Research Area cluster PREMOS, calls attention to the translational value of animal models in brain research.
Including cranberries in your diet has a whole host of benefits - it can improve memory and brain function, lower ‘bad’ cholesterol and prevent dementia.
More than half of neurointerventionalists, neurosurgeons, neurologists and radiologists are currently experiencing burnout as a result of provider shortages, covering multiple hospitals simultaneously, and increasing demand for emergency stroke care, and this is only expected to get worse.
To improve understanding of the impact and epidemiology of Alzheimer’s disease, Project Alzheimer’s Value Europe (PAVE) demonstrates the prevalence of Alzheimer’s across the stages of the disease, including prodromal and preclinical – which aren’t recognised by previous studies.
